Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Monday, June 23, 2025 · 824,921,965 Articles · 3+ Million Readers

Key Trend Shaping The Mycobacterium Tuberculosis Market In 2025: Advancements In Automated Tuberculosis Testing

The Business Research Company

The Business Research Company

The Business Research Company's Mycobacterium Tuberculosis Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034”
— The Business Research Company

LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034

In recent years, the mycobacterium tuberculosis market size has demonstrated strong growth, rising from $3.54 billion in 2024 to an anticipated $3.74 billion in 2025. This represents a compound annual growth rate CAGR of 5.5%. The robust growth within this historical period can largely be attributed to the increasing number of tuberculosis TB cases present in countries with high disease burden, expanding TB screening programs, and a rise in TB-HIV co-infections. However, these aren't the only contributors - global travel and migration have also played a key role in spreading TB.

What Is The Projected Growth Of The Mycobacterium Tuberculosis Market?
Looking forward, the mycobacterium tuberculosis market size is projected to grow significantly. By 2029, the market could reach $4.57 billion, exhibiting a CAGR of 5.2%. Several factors will drive this predicted growth, including a global rise in TB prevalence, an increase in drug-resistant TB cases, heightened awareness of TB transmission and prevention, and Government-led initiatives and funding for TB elimination. Additionally, research and development in TB treatment will also catalyze growth in the market. Major trends for the forecast period include advancements in TB diagnostic technologies, the availability of rapid TB testing methods, the introduction of new TB vaccines, development of novel drug regimens for multidrug-resistant TB, and significant advancements in TB drug formulation.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24325&type=smp

What Drives The Growth Of The Mycobacterium Tuberculosis Market?
Investments in research and development are also set to propel the growth of the mycobacterium tuberculosis market. With the rapid advancement of technology, there is a significant need for continuous innovation to remain competitive in the global market. Research and development help improve existing products, services, or technologies and pave the way for new knowledge. To overcome resistance to existing therapies, the creation of new drug candidates via systematic investigation and experimentation is mission-critical. This improves the effectiveness of treatment and leads to better patient outcomes.

Who Are The Key Players In The Mycobacterium Tuberculosis Market?
An array of companies operate within the mycobacterium tuberculosis market including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd, Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, and Akonni Biosystems Inc.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/mycobacterium-tuberculosis-global-market-report

What Are The Emerging Trends In The Mycobacterium Tuberculosis Market?
Companies are focusing on developing advanced solutions, such as automated tuberculosis tests, to deliver faster and more accurate results. In April 2025, a U.S. biotechnology company, Revvity Inc., announced FDA approval for the Auto-Pure 2400 liquid handling platform with the T-SPOT TB test. The T-SPOT.TB test, recognized by the WHO as the only ELISPOT-based IGRA, ensures reproducible results with fewer indeterminate outcomes, and reliable performance in immunocompromised patients.

What Is The Market Segmentation Of The Mycobacterium Tuberculosis Sector?
The mycobacterium tuberculosis market is segmented by product type instruments, reagents and consumables, software solutions, diagnostic methods culture-based methods, molecular diagnosis, immunological tests, route of administration oral, Injectable, and end-user hospitals, diagnostic laboratories, research institutions. It is further subdivided by instruments diagnostic instruments, detection instruments, molecular diagnostic instruments, tuberculosis culture systems, reagents and consumables polymerase chain reaction reagents, tuberculosis culture media, antigen kits, test strips, tuberculosis diagnostic kits and software solutions laboratory information management systems, diagnostic software, data management software, telemedicine solutions for TB diagnosis.

What Are The Regional Insights Into The Mycobacterium Tuberculosis Market?
North America was the largest region in the mycobacterium tuberculosis market in 2024. In the forecast period, Asia-Pacific is expected to be the fastest-growing region. The report covers global regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Acute Bacterial Skin And Skin Structure Infections Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Antibacterial Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report

Bacterial And Plasmid Vectors Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+ +44 20 7193 0708
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Powered by EIN Presswire

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry, International Organizations, Technology, World & Regional

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release